# Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies

> **NCT00036023** · PHASE2 · COMPLETED · sponsor: **Amgen**

## Conditions studied

- Lymphoma
- Breast Neoplasms
- Lung Neoplasms
- Multiple Myeloma
- Chronic Lymphocytic Leukemia

## Interventions

- **DRUG:** darbepoetin alfa

## Key facts

- **NCT ID:** NCT00036023
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2009-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00036023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00036023, "Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00036023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*